10 mg lyophilised · single compound
$85.00 CAD
Thymosin Alpha-1 is a peptide based on a natural immune-signalling molecule from the thymus gland. It is studied for how it influences immune-cell activity and the body's defence responses.
For laboratory and research use only - not for human consumption.
Checking the live COA archive for the newest lot documentation.
Use the verification archive to select a peptide name and review all published lot records alphabetically.
View previous lab resultsThymosin Alpha-1 (Tα1) is a 28-amino-acid peptide derived from prothymosin alpha, originally identified in the thymus (the gland that helps train the immune system). It acts as an immune modulator (it tunes immune activity up or down rather than simply stimulating it).
It has a long clinical-research history, including large trials, for immune-related conditions. Mechanistically it increases the number and activity of T-cells and natural-killer cells (immune “soldiers”) and helps balance inflammatory signalling. It is studied as an immunomodulator across infection and cancer-support research.
Thymosin Alpha-1 engages innate and adaptive immunity at several points - including Toll-like-receptor signalling - boosting protective immune responses while moderating excessive inflammation.
Thymosin Alpha-1 is approved in more than 35 countries (brand name Zadaxin) for chronic hepatitis B and as an immunomodulator, but it is not approved by the U.S. FDA or the European Medicines Agency. The material here is an unapproved research compound - not a medicine, and not for human consumption.
A single vial containing 10 mg of Thymosin Alpha-1 as a lyophilised powder.
